Chemotherapy and hemostasis disorders

Cancer patients are at risk of developing arterial and venous thrombosis during chemotherapy (CT) and after its cessation. A prothrombotic risk may arise via pathogenetic pathways such as activation of external and internal coagulation pathways, decreased anticoagulant levels, platelet activation, f...

Full description

Bibliographic Details
Published in:Акушерство, гинекология и репродукция
Main Authors: E. V. Slukhanchuk, V. O. Bitsadze, A. G. Solopova, J. Kh. Khizroeva, K. N. Grigoreva, N. R. Gashimova, N. A. Makatsariya, D. V. Blinov, V. N. Galkin, A. Yu. Shatilina, E. M. Lyadnova, N. A. Shulga, L. T. Toguzaeva, S. Morkos, J.-C. Gris, I. Elalamy, G. Gerotziafas, A. D. Makatsariya
Format: Article
Language:Russian
Published: IRBIS LLC 2025-01-01
Subjects:
cancer
venous thromboembolism
thrombosis
chemotherapy
ст
Online Access:https://www.gynecology.su/jour/article/view/2288

Internet

https://www.gynecology.su/jour/article/view/2288

Similar Items